Flash talks on asthma

Farm-dust mediated asthma protection in childhood: Dendritic cell-mediated T cell priming

Reduction of systemic corticosteroid courses in severe asthmatic patients receiving a biological treatment

Correlates of barriers to PROMs use among physicians who use PROMS for atopic dermatitis and chronic urticaria

Omalizumab tapering and discontinuation in severe Chronic Urticaria

Omalizumab updosing in Chronic Spontaneous Urticaria non-responder patients

What topics are doctors most interested in learning about patient-reported outcomes (PROM) when addressing patients with chronic urticaria or atopic dermatitis?

Identification of biomarkers for treatment duration and controller dose of omalizumab in patients with chronic spontaneous urticaria

Natural course of Acute Urticaria and predictive factors associated with progression to Chronic Urticaria: Initial results of a prospective study in the emergency department of a Tertiary University Hospital in Greece

Comparison of 150-300 mg doses of omalizumab according to efficacy and safety in patients with chronic spontaneous urticaria

Serological profiling in chronic urticaria